| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. | Proc Natl Acad Sci U S A | 2003 | 1.64 |
| 2 | Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. | Cardiovasc Drugs Ther | 2005 | 1.05 |
| 3 | Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. | J Pharmacol Exp Ther | 2005 | 0.96 |